Bliss GVS Pharma Ltd. (BLISSGVS-BE) Share Price Hits Fresh 52-Week High

Bliss GVS Pharma Ltd. Share Price rose 5% to Rs 572.70, its fresh 52-week high, taking market capitalisation to Rs 5,521 crore.

Bliss GVS Pharma Ltd. Share Price moved up to Rs 572.70 on 19 August 2026, a gain of Rs 27.25 or 5% from the previous close of Rs 545.45, while marking a fresh 52-week high. The stock opened at Rs 569.75, traded between Rs 551.05 and Rs 572.70 during the session, and the company’s market capitalisation stood at Rs 5,521 crore.

For readers tracking Bliss GVS Pharma Ltd. Share Price Today and Bliss GVS Pharma Ltd. Stock News, the verified data confirms a clear price event: the stock touched a new one-year high and was trading at the top of its day’s range. Turnover stood at Rs 1.51 crore with current volume of 26,390 shares, showing active participation around the yearly high.

What the supplied data establishes is the price breakout itself, not a company-specific catalyst. That still makes this a relevant stock analysis event because fresh 52 Week High stocks often attract attention across Stock Market Today screens, Market Movers lists and momentum-focused watchlists. In Univest’s view, the next things to monitor are whether Bliss GVS Pharma Ltd. Share Price can hold near this 52-week peak, how its valuation compares with the Healthcare benchmark, and whether its profitability metrics support continued investor interest.

Bliss GVS Pharma Ltd. Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 572.7
Previous Close	Rs 545.45
Today's Change	+Rs 27.25 (+5%)
Day Open	Rs 569.75
Fresh 52-Week High	Rs 572.7
Day Low	Rs 551.05
Current Volume	26,390
Turnover	Rs 1.51 crore
Market Capitalisation	Rs 5,521 crore

Bliss GVS Pharma Ltd. (BLISSGVS-BE) traded at Rs 572.7. versus the previous close of Rs 545.45, a rise of 5%. The stock opened at Rs 569.75, reached Rs 572.7, touched Rs 551.05. Reported volume was 26,390.

Bliss GVS Pharma Ltd. Share Price Today reflects a strong session on verified price data alone. The stock rose 5% from the previous close of Rs 545.45 to Rs 572.70, opened at Rs 569.75, touched a low of Rs 551.05 and hit a fresh 52-week high of Rs 572.70.

The day’s move is notable because the stock finished its intraday climb at the same level as its 52-week high, indicating that the session’s strongest quoted price was also the new one-year high. A rise of Rs 27.25 from the previous close is meaningful on an event-driven basis, especially when the stock is appearing in 52 Week High Stocks and Stocks in News screens.

Intraday positioning also matters. Opening at Rs 569.75 and then reaching Rs 572.70 shows the stock stayed close to the upper end of its session range for much of the move, even after dipping to Rs 551.05. That places Bliss GVS Pharma Ltd. Share Price near the top of the day’s price action rather than merely tagging the level briefly.

Trading turnover of Rs 1.51 crore and volume of 26,390 shares indicate measurable market participation behind the move. The supplied data confirms the breakout event, but it does not establish a company-specific reason for why the stock is rising today. For investors following Bliss GVS Pharma Ltd. Share News and Bliss GVS Pharma Ltd. Share Price Live, the next step is to judge whether the current move is supported by the company’s valuation and return profile.

Bliss GVS Pharma Ltd. (BLISSGVS-BE) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 5,521 crore
P/E Ratio	51.17x
P/B Ratio	2.03x
ROE	-0.78%
ROCE	8.31%

Bliss GVS Pharma Ltd. was valued at a P/E ratio of 51.17x, a P/B ratio of 2.03x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of -0.78% and ROCE of 8.31%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Company P/E Ratio	51.17x
Benchmark Median P/E	20.79x
Benchmark Average P/E	47.16x
Benchmark P/E Range	0x to 1,635.98x
Company P/B Ratio	2.03x
Benchmark Median P/B	1.9x
Company ROE	-0.78%
Benchmark Median ROE	11.09%
Company ROCE	8.31%
Benchmark Median ROCE	13.29%
Company Market Capitalisation	Rs 5,521 crore
Benchmark Median Market Cap	Rs 134.22 crore

Bliss GVS Pharma Ltd. (BLISSGVS-BE) is classified under sector: Healthcare.

Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a P/E ratio of 51.17x, which is above the benchmark median of 20.79x, a difference of +146.13%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a ROE of -0.78%, which is below the benchmark median of 11.09%, a difference of -107.03%. Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a ROCE of 8.31%, which is below the benchmark median of 13.29%, a difference of -37.47%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Ind-Swift Laboratories Ltd.	INDSWFTLAB	2,724.51	51.17	2.03	-0.78	8.31
Beta Drugs Ltd.	BETA	2,697.08	62.93	9.96	18.65	22.17
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,583.65	33.9	6.99	36.29	42.4
Sai Parenteral's Ltd.	SAIPARENT	2,431.62	167.79	3.07	13.9	12.97
Fredun Pharmaceuticals Ltd.	FREDUN	2,403.56	54.45	8.13	11.42	13.15

Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a P/E ratio of 51.17x compared with the displayed peer median of 54.45x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -0.78% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at 8.31% versus the displayed peer median of 13.15%, providing a capital-efficiency comparison. Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a market capitalisation of Rs 5,521 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching Bliss GVS Pharma Ltd.

The current attention around Bliss GVS Pharma Ltd. Share Price is grounded in verified market data and relative valuation context rather than any stated corporate trigger.

• Fresh price event: the stock hit a new 52-week high of Rs 572.70 and rose 5% in the session.
• Strong intraday placement: the day’s high matched the current price, showing the stock was trading at the top of the session range.
• Meaningful activity: turnover reached Rs 1.51 crore with volume of 26,390 shares.
• Large market size: market capitalisation of Rs 5,521 crore is above the supplied Healthcare benchmark average and median.
• Valuation debate: P/E of 51.17 is above the sector median of 20.79 and above the average of 47.16.
• Return profile: ROE of -0.78% and ROCE of 8.31% trail the sector medians of 11.09% and 13.29%.
• Peer relevance: the stock is larger than the supplied peers by market cap, but not stronger on the supplied return ratios.

About Bliss GVS Pharma Ltd.

Bliss GVS Pharma Ltd. is being tracked here as a listed Healthcare company under the symbol BLISSGVS-BE. The supplied dataset places it within the Healthcare sector, which is the reference universe used for the valuation and profitability benchmark in this article.

Because this report is built only from verified event data, the focus remains on what can be confirmed in the supplied record: the company’s market value, its fresh 52-week high, and how Bliss GVS Pharma Ltd. Share Price compares with sector and peer metrics. In the current Market News cycle, that is enough to place the stock on investor watchlists even without adding unsupported business detail.

For readers using Univest for Bliss GVS Pharma Ltd. Stock News, the stock is currently notable for its one-year high, its Rs 5,521 crore market capitalisation, and a valuation profile that sits above broad Healthcare earnings benchmarks while showing lower supplied return ratios than many peers.

Track Bliss GVS Pharma Ltd. Share Price on Univest

Use Bliss GVS Pharma Ltd. (BLISSGVS-BE) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

On Univest, users can track Bliss GVS Pharma Ltd. Share Price through live market updates, 52-week levels, price performance, turnover trends and broader stock analysis. The platform also helps investors follow key fundamental ratios such as market cap, P/E, P/B, ROE and ROCE in one place.

For readers monitoring Bliss GVS Pharma Ltd. Share Price Today, Univest also brings together peer comparison, sector benchmark context and day-by-day market insights. That makes it easier to place a fresh 52-week high in context rather than viewing the price move in isolation. As this event shows, a one-year high can draw attention quickly, but the more useful question is how the price action compares with valuation and sector positioning.

Frequently Asked Questions

What is the latest Bliss GVS Pharma Ltd. Share Price Today?

Ans. Bliss GVS Pharma Ltd. Share Price Today is Rs 572.70. The stock was up Rs 27.25, or 5%, from the previous close of Rs 545.45, and this move also marked a fresh 52-week high during the session.

Why is Bliss GVS Pharma Ltd. Share Price in focus today?

Ans. The stock is in focus because it hit a fresh 52-week high of Rs 572.70 on 19 August 2026. The supplied data confirms the price breakout and a 5% daily gain, though it does not establish a company-specific catalyst.

What was the intraday range for Bliss GVS Pharma Ltd. Share Price?

Ans. Bliss GVS Pharma Ltd. Share Price opened at Rs 569.75, touched an intraday low of Rs 551.05 and reached a high of Rs 572.70. That means the stock ended up trading at the same level as its fresh yearly high.

What is the market capitalisation of Bliss GVS Pharma Ltd.?

Ans. Bliss GVS Pharma Ltd. had a market capitalisation of Rs 5,521 crore in the supplied dataset. That is well above the Healthcare sector benchmark median of Rs 134.22 crore and also above the benchmark average of Rs 465.93 crore.

How does Bliss GVS Pharma Ltd. compare on P/E ratio?

Ans. The company’s P/E ratio is 51.17. This is above the Healthcare benchmark median of 20.79 and also above the benchmark average of 47.16, indicating that the stock trades at a richer earnings multiple than broad sector norms.

What does the P/B ratio of Bliss GVS Pharma Ltd. show?

Ans. Bliss GVS Pharma Ltd. has a P/B ratio of 2.03. That is slightly above the Healthcare sector median of 1.9 but below the sector average of 2.57, placing its balance-sheet valuation closer to the middle of the benchmark range.

How strong are the return ratios of Bliss GVS Pharma Ltd.?

Ans. The supplied data shows ROE at -0.78% and ROCE at 8.31%. Both are below the Healthcare benchmark medians of 11.09% and 13.29%, so the current one-year high is not accompanied by top-tier return ratios.

How active was trading in Bliss GVS Pharma Ltd. shares today?

Ans. Trading volume stood at 26,390 shares, while turnover was Rs 1.51 crore. Those figures indicate active participation on the day the stock rose 5% and touched its fresh 52-week peak at Rs 572.70.

How does Bliss GVS Pharma Ltd. compare with the supplied peers?

Ans. Bliss GVS Pharma Ltd. has a market cap of Rs 5,521 crore, larger than all supplied peers. However, its ROE of -0.78% and ROCE of 8.31% are weaker than Beta Drugs, Dr Agarwals Eye Hospital, Sai Parenteral's and Fredun Pharmaceuticals.

What should investors monitor after this 52-week high?

Ans. Investors can monitor whether Bliss GVS Pharma Ltd. Share Price holds near Rs 572.70, how valuation at 51.17 times earnings evolves, and whether future data improves return ratios that currently stand at ROE of -0.78% and ROCE of 8.31%.